Beta-Elemonic acidCAS# 28282-25-9 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
| Cas No. | 28282-25-9 | SDF | Download SDF |
| PubChem ID | 17751006 | Appearance | White powder |
| Formula | C30H46O3 | M.Wt | 454.7 |
| Type of Compound | Triterpenoids | Storage | Desiccate at -20°C |
| Synonyms | Elemadienonic acid; 3-Oxotirucallic acid | ||
| Solubility | Sparingly soluble in methanol; practically insoluble in water | ||
| Chemical Name | (2S)-6-methyl-2-[(10S,14S,17S)-4,4,10,13,14-pentamethyl-3-oxo-1,2,5,6,7,11,12,15,16,17-decahydrocyclopenta[a]phenanthren-17-yl]hept-5-enoic acid | ||
| SMILES | CC(=CCCC(C1CCC2(C1(CCC3=C2CCC4C3(CCC(=O)C4(C)C)C)C)C)C(=O)O)C | ||
| Standard InChIKey | XLPAINGDLCDYQV-XUWOXAENSA-N | ||
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
| About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
| Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. | ||
| Description | 1. Beta-Elemonic acid exhibits anti-inflammatory effects. 2. Beta-Elemonic acid inhibits proliferation by inducing hypoploid cells and cell apoptosis, the anticancer effects of beta-Elemonic acid are related to the MAPK signaling pathway, ROS activation and glutathione depletion in human A549 lung cancer cells. 3. Beta-Elemonic acid exhibits prolyl endopeptidase inhibitory activities. |
| Targets | MAPK | ROS | COX | Bcl-2/Bax |
Beta-Elemonic acid Dilution Calculator
Beta-Elemonic acid Molarity Calculator
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 2.1993 mL | 10.9963 mL | 21.9925 mL | 43.985 mL | 54.9813 mL |
| 5 mM | 0.4399 mL | 2.1993 mL | 4.3985 mL | 8.797 mL | 10.9963 mL |
| 10 mM | 0.2199 mL | 1.0996 mL | 2.1993 mL | 4.3985 mL | 5.4981 mL |
| 50 mM | 0.044 mL | 0.2199 mL | 0.4399 mL | 0.8797 mL | 1.0996 mL |
| 100 mM | 0.022 mL | 0.11 mL | 0.2199 mL | 0.4399 mL | 0.5498 mL |
| * Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. | |||||
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Baicalein 6-O-glucoside
Catalog No.:BCN3325
CAS No.:28279-72-3
- Tyrphostin A1
Catalog No.:BCC5404
CAS No.:2826-26-8
- Reynosin
Catalog No.:BCN5178
CAS No.:28254-53-7
- HOOBt
Catalog No.:BCC2817
CAS No.:28230-32-2
- Phlorin
Catalog No.:BCN5177
CAS No.:28217-60-9
- JTE 907
Catalog No.:BCC7380
CAS No.:282089-49-0
- Lauterine
Catalog No.:BCN7062
CAS No.:28200-65-9
- Dihydrodehydrodiconiferyl alcohol
Catalog No.:BCN5176
CAS No.:28199-69-1
- Sinensin
Catalog No.:BCN4797
CAS No.:28189-90-4
- 5-Amino-2-mercaptobenzimidazole
Catalog No.:BCC8730
CAS No.:2818-66-8
- Futoquinol
Catalog No.:BCN6416
CAS No.:28178-92-9
- CHC
Catalog No.:BCC7994
CAS No.:28166-41-8
- Daurinoline
Catalog No.:BCN2742
CAS No.:2831-75-6
- 5-Hydroxy-1-tetralone
Catalog No.:BCN8397
CAS No.:28315-93-7
- Valifenalate
Catalog No.:BCC8071
CAS No.:283159-90-0
- Fmoc-ß-HoAsn(Trt)-OH
Catalog No.:BCC3228
CAS No.:283160-20-3
- Rucaparib (free base)
Catalog No.:BCC4012
CAS No.:283173-50-2
- 11beta-Hydroxycedrelone
Catalog No.:BCN5179
CAS No.:283174-18-5
- sn-Glycero-3-phosphocholine
Catalog No.:BCC4168
CAS No.:28319-77-9
- IVHD-valtrate
Catalog No.:BCN7125
CAS No.:28325-56-6
- 6-Ethoxydihydrosanguinarine
Catalog No.:BCN7589
CAS No.:28342-31-6
- Oxychelerythrine
Catalog No.:BCN4864
CAS No.:28342-33-8
- Canolol
Catalog No.:BCC8371
CAS No.:28343-22-8
- Mahanine
Catalog No.:BCN3176
CAS No.:28360-49-8
beta-Elemonic acid inhibits the cell proliferation of human lung adenocarcinoma A549 cells: The role of MAPK, ROS activation and glutathione depletion.[Pubmed:26530631]
Oncol Rep. 2016 Jan;35(1):227-34.
Beta-Elemonic acid, a known triterpene, exhibits anti-inflammatory effects, yet research on the pharmacological effects of Beta-Elemonic acid is rare. We investigated the anticancer effects and the related molecular mechanisms of Beta-Elemonic acid on human non-small cell lung cancer (NSCLC) A549 cells. The effects of Beta-Elemonic acid on the growth of A549 cells were studied using a 3-(4,5)-2,5-diphenyltetrazolium bromide (MTT) assay. Apoptosis was detected using Annexin V staining. The effect of Beta-Elemonic acid on the cell cycle of A549 cells was assessed using the propidium iodide method. The change in reactive oxygen species (ROS) was detected using a dichlorodihydrofluorescein diacetate (DCFH-DA) assay with microscopic examination. The expression levels of Bcl-2 family proteins, mitogen-activated protein kinase (MAPK) family proteins and cyclooxygenase 2 (COX-2) were detected using western blot analysis. Our data revealed that Beta-Elemonic acid strongly induced human A549 lung cancer cell death in a dose- and time-dependent manner as determined by the MTT assay. Beta-Elemonic acid-induced cell death was considered to be apoptotic when the phosphatidylserine exposure was observed using Annexin V staining. The death of human A549 lung cancer cells was caused by apoptosis induced by activation of ROS activity, increase in the sub-G1 proportion, downregulation of Bcl-2 expression, upregulation of Bax expression and inhibition of the MAPK signaling pathways. These results clearly demonstrated that Beta-Elemonic acid inhibits proliferation by inducing hypoploid cells and cell apoptosis. Moreover, the anticancer effects of Beta-Elemonic acid were related to the MAPK signaling pathway, ROS activation and glutathione depletion in human A549 lung cancer cells.
Bioactive constituents from Boswellia papyrifera.[Pubmed:15730241]
J Nat Prod. 2005 Feb;68(2):189-93.
Phytochemical investigation of the stem bark extract of Boswellia papyrifera afforded two new stilbene glycosides, trans-4',5-dihydroxy-3-methoxystilbene-5-O-{alpha-L-rhamnopyranosyl-(1-->2)-[alph a-L-rhamnopyranosyl-(1-->6)]-beta-D-glucopyranoside (1), trans-4',5-dihydroxy-3-methoxystilbene-5-O-[alpha-L-rhamnopyranosyl-(1-->6)]-beta -D-glucopyranoside (2), and a new triterpene, 3alpha-acetoxy-27-hydroxylup-20(29)-en-24-oic acid (3), along with five known compounds, 11-keto-beta-boswellic acid (4), Beta-Elemonic acid (7), 3alpha-acetoxy-11-keto-beta-boswellic acid (8), beta-boswellic acid (9), and beta-sitosterol (10). The stilbene glycosides exhibited significant inhibition of phosphodiesterase I and xanthine oxidase. The triterpenes (3-9) exhibited prolyl endopeptidase inhibitory activities.
